10-47322699-C-CCCCTGCTGT
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM4BP6_ModerateBS2
The NM_016204.4(GDF2):c.40_48dup(p.Ser14_Leu16dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,584,190 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00091 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
GDF2
NM_016204.4 inframe_insertion
NM_016204.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.911
Genes affected
GDF2 (HGNC:4217): (growth differentiation factor 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates cartilage and bone development, angiogenesis and differentiation of cholinergic central nervous system neurons. Mutations in this gene are associated with hereditary hemorrhagic telangiectasia. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_016204.4.
BP6
Variant 10-47322699-C-CCCCTGCTGT is Benign according to our data. Variant chr10-47322699-C-CCCCTGCTGT is described in ClinVar as [Likely_benign]. Clinvar id is 1110451.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 138 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDF2 | NM_016204.4 | c.40_48dup | p.Ser14_Leu16dup | inframe_insertion | 1/2 | ENST00000581492.3 | NP_057288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDF2 | ENST00000581492.3 | c.40_48dup | p.Ser14_Leu16dup | inframe_insertion | 1/2 | 1 | NM_016204.4 | ENSP00000463051 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000907 AC: 138AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
138
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000165 AC: 39AN: 236356Hom.: 1 AF XY: 0.000132 AC XY: 17AN XY: 129114
GnomAD3 exomes
AF:
AC:
39
AN:
236356
Hom.:
AF XY:
AC XY:
17
AN XY:
129114
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000120 AC: 172AN: 1431878Hom.: 0 Cov.: 31 AF XY: 0.0000933 AC XY: 66AN XY: 707578
GnomAD4 exome
AF:
AC:
172
AN:
1431878
Hom.:
Cov.:
31
AF XY:
AC XY:
66
AN XY:
707578
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000906 AC: 138AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000940 AC XY: 70AN XY: 74474
GnomAD4 genome
AF:
AC:
138
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
70
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
GDF2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Telangiectasia, hereditary hemorrhagic, type 5 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at